Evaluation of Angiopoietin-2 as a biomarker in gastric cancer: results from the randomised phase III AVAGAST trial.
about
New agents on the horizon in gastric cancer.Anti-angiogenic Therapy in Patients with Advanced Gastric and Gastroesophageal Junction Cancer: A Systematic Review.Angiogenesis and Anti-Angiogenic Therapy in Gastric Cancer.Angiogenesis inhibitors in early development for gastric cancer.Regional differences in advanced gastric cancer: exploratory analyses of the AVAGAST placebo arm.Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges.Radical Gastrectomy: Still the Cornerstone of Curative Treatment for Gastric Cancer in the Perioperative Chemotherapy Era-A Single Institute Experience over a Decade.Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directions.
P2860
Q38759129-524F56C9-F7AA-4FD0-8FCA-62B22A034DAFQ39067386-CBC93A27-CDA9-42D1-A7D5-FE8B7EA63704Q47218543-2100E039-9114-4B54-BA91-75A1FB646D6CQ47996955-D67A8617-3B4E-43FA-93FB-9AFF6E6DD243Q48569564-F0719EC6-EC55-47BB-9DB8-4F19C18F0F01Q55190117-C3C309EB-1B9C-42C5-A3AC-C30B90C651B9Q55286343-2458915C-119D-4412-9CC4-0830C1014EDEQ55654316-2EC98E72-FC0E-4D8D-A49E-61888C3EC5C2
P2860
Evaluation of Angiopoietin-2 as a biomarker in gastric cancer: results from the randomised phase III AVAGAST trial.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 March 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evaluation of Angiopoietin-2 a ...... mised phase III AVAGAST trial.
@en
Evaluation of Angiopoietin-2 a ...... mised phase III AVAGAST trial.
@nl
type
label
Evaluation of Angiopoietin-2 a ...... mised phase III AVAGAST trial.
@en
Evaluation of Angiopoietin-2 a ...... mised phase III AVAGAST trial.
@nl
prefLabel
Evaluation of Angiopoietin-2 a ...... mised phase III AVAGAST trial.
@en
Evaluation of Angiopoietin-2 a ...... mised phase III AVAGAST trial.
@nl
P2093
P2860
P356
P1476
Evaluation of Angiopoietin-2 a ...... mised phase III AVAGAST trial.
@en
P2093
Eric Van Cutsem
Hildegard Büning
Lars Schiffmann
Laura Escalona-Espinosa
Nicola Consalvo
Oliver Coutelle
Priti Hedge
Stefan J Scherer
Ulrich T Hacker
Valentin Goede
P2860
P2888
P304
P356
10.1038/BJC.2016.30
P407
P577
2016-03-31T00:00:00Z